Your Cart is Empty
CM Core, 90 caps
$ 49.70
| Qty | Discount |
|---|---|
| Buy 3 | 3% Off |
| Buy 5 | 5% Off |
Free Shipping On Orders over $50
Nutritionist Approved
60-Day Return GuaranteeDESCRIPTION
CM Core provides multidimensional support for cardiovascular health by maintaining healthy cholesterol levels and supporting blood sugar balance already within normal levels. Clinical research shows that maintaining optimal cardiovascular health should address multiple metabolic factors.
CM Core, a formula backed by extensive clinical research, is designed to address several factors associated with ideal cardiometabolic health. The powerful combination of berberine and alpha lipoic acid (ALA) helps maintain heart function, metabolism, antioxidant status, and lipid and glucose levels. CM Core provides a powerful formula for those seeking to optimize the multiple mechanisms of cardiovascular and metabolic health.
Benefits of CM Core may include:
- Multidimensional Support for Cardiovascular Health
- Enhances Cell Signaling for Efficient ATP Production
- Supports Blood Sugar Balance Already Within Normal Levels
- Maintains Healthy Cholesterol Levels
INGREDIENTS
Ingredients:
- Vitamin C (as Ascorbyl Palmitate)
- Berberine Hydrochloride Hydrate
- Alpha Lipoic Acid
Other Ingredients: Natural Vegetable capsules, Microcrystalline Cellulose, Magnesium Stearate, and Silicon Dioxide
Formulated to be free of allergens derived from: Gluten, corn, yeast, artificial colors and flavors.
DIRECTIONS
Serving Size: 3 capsules
Servings per container: 30
Suggested Use: 3 capsules per day or as recommended by your health care professional
If you are pregnant or nursing, consult your health care professional before taking this product.
Keep container tightly closed. Store at room temperature. Keep out of reach of children.
LEARN MORE
INGREDIENT BENEFITS:
Berberine:Berberine is a plant extract that has been used in Chinese and Ayurvedic medicine for over 2,500 years for its broad range of health-promoting properties. Berberine can be found in the roots and stems of plants such as Hydastatis canadensis (goldenseal), Coptis chinensis (goldenthread), Berberis aquifolium (Oregon grape) and Berberis vulgaris (barberry). Clinical trials have demonstrated that berberine administration supports cardiovascular health in a number of synergistic ways.
Alpha Lipoic Acid (ALA):Alpha lipoic acid (ALA) is a nutrient required for cellular metabolism, specifically the breakdown of carbohydrates and fatty acids. ALA has been shown to support blood sugar balance already within normal levels by activating AMPK, a major regulator of cellular energy.
Statements contained herein have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease.
References
1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC. Diagnosis and management of the metabolic syndrome an american heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005;112:2735-2752.
2. Jeong HW, Hsu KC, Lee J-W, Ham M, Huh JY, Shin HJ, Kim WS, Kim JB. Berberine suppresses proinflammatory responses through ampk activation in macrophages. American Journal of Physiology-Endocrinology And Metabolism. 2009;296:E955-E964.
3. Kemp B, Stapleton D, Campbell D, Chen Z-P, Murthy S, Walter M, Gupta A, Adams J, Katsis F, van Denderen B. Amp-activated protein kinase, super metabolic regulator. Biochemical Society Transactions. 2003;31:162-168.
4. Towler MC and Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circulation research. 2007;100:328-341.
5. Lau CW, Yao XQ, Chen ZY, Ko WH and Huang Y. Cardiovascular actions of berberine. Cardiovascular Drug Reviews. 2001;19:234-244.
6. Brusq J-M, Ancellin N, Grondin P, Guillard R, Martin S, Saintillan Y and Issandou M. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. Journal of lipid research. 2006;47:1281-1288.
7. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S and Pan H. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature medicine. 2004;10:1344-1351.
8. Derosa G, D’Angelo A, Bonaventura A, Bianchi L, Romano D and Maffioli P. Effects of berberine on lipid profile in subjects with low cardiovascular risk. Expert opinion on biological therapy. 2013;13:475-482.
9. Zhang H, Wei J, Xue R, Wu J-D, Zhao W, Wang Z-Z, Wang S-K, Zhou Z-X, Song D-Q and Wang Y-M. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism. 2010;59:285-292.
2. Jeong HW, Hsu KC, Lee J-W, Ham M, Huh JY, Shin HJ, Kim WS, Kim JB. Berberine suppresses proinflammatory responses through ampk activation in macrophages. American Journal of Physiology-Endocrinology And Metabolism. 2009;296:E955-E964.
3. Kemp B, Stapleton D, Campbell D, Chen Z-P, Murthy S, Walter M, Gupta A, Adams J, Katsis F, van Denderen B. Amp-activated protein kinase, super metabolic regulator. Biochemical Society Transactions. 2003;31:162-168.
4. Towler MC and Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circulation research. 2007;100:328-341.
5. Lau CW, Yao XQ, Chen ZY, Ko WH and Huang Y. Cardiovascular actions of berberine. Cardiovascular Drug Reviews. 2001;19:234-244.
6. Brusq J-M, Ancellin N, Grondin P, Guillard R, Martin S, Saintillan Y and Issandou M. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. Journal of lipid research. 2006;47:1281-1288.
7. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S and Pan H. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature medicine. 2004;10:1344-1351.
8. Derosa G, D’Angelo A, Bonaventura A, Bianchi L, Romano D and Maffioli P. Effects of berberine on lipid profile in subjects with low cardiovascular risk. Expert opinion on biological therapy. 2013;13:475-482.
9. Zhang H, Wei J, Xue R, Wu J-D, Zhao W, Wang Z-Z, Wang S-K, Zhou Z-X, Song D-Q and Wang Y-M. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism. 2010;59:285-292.